Ignite Creation Date:
2025-12-24 @ 7:48 PM
Ignite Modification Date:
2026-01-01 @ 8:52 PM
Study NCT ID:
NCT07052903
Status:
RECRUITING
Last Update Posted:
2025-12-19
First Post:
2025-06-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Sponsor:
Alnylam Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-02
Start Date Type:
ACTUAL
Primary Completion Date:
2030-05-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2032-11-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-06-30
First Submit QC Date:
None
Study First Post Date:
2025-07-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-18
Last Update Post Date:
2025-12-19
Last Update Post Date Type:
ESTIMATED